In a statement released on March 21, 2014, the U.S Food and Drug Administration announced that the FDA approved a new drug to treat adults with active psoriatic arthritis (PsA). The new drug is “Otezla”, and Bill Berkot, in “Update 2- U.S.
The FDA recently approved a new drug application to treat tinea corporis, tinea cruris, and tinea pedis. The drug is luliconazole, a topical azole antifungal cream.
Luliconazole is approved for a 1-week, once-daily treatment regimen treatment course in adults over 18 years old with tinea corporis or tinea cruris. Treatment for interdigital tinea pedis is once daily for 2 weeks.
Australia, home of some of the highest skin-cancer rates in the world, recently announced a complete ban on tanning beds. Skin cancer led to 2,000 deaths in 2011 in Australia and is responsible for 80% of all new cancer cases diagnosed each year. In light of these statistics, five of Australia’s eight states and territories plan on completely banning tanning beds by 2015; New South Wales is implementing the ban at the end of the year.